|
1 - 20
|
 |
Breast reconstruction can have lasting benefits
July 4, 2008
NEW YORK (Reuters Health) - Breast reconstruction after cancer surgery can have lasting benefits for women's psychological well-being and body image, a new study suggests.
|
|
Doctors extract cancer cells from blood sample
July 3, 2008
BOSTON (Reuters) - An experimental process that snags lung cancer cells from a blood sample could give doctors real-time feedback on the most effective therapy, researchers reported on Wednesday.
|
|
Tumor-starving pill helps thyroid cancer: study
July 3, 2008
WASHINGTON (Reuters) - Amgen's once-a-day pill to starve tumors can help many patients with hard-to-treat thyroid cancer, either by shrinking tumors or slowing their growth, researchers reported on Wednesday.
|
|
Heart failure linked to Sutent treatment
July 2, 2008
NEW YORK (Reuters Health) - Kidney and stomach cancer patients given the chemotherapy drug Sutent (also called sunitinib), especially those with cardiac risk factors, need to be closely monitored for signs of heart trouble, results of a study confirm.
|
|
Biomarkers needed to gauge passive smoke exposure
July 2, 2008
NEW YORK (Reuters Health) - Biological indicators, or "biomarkers" of exposure to secondhand smoke that can be analyzed in blood, tissue or other samples, or through imaging scans are needed to examine whether exposure to secondhand smoke may cause lung cancer.
|
|
High fat diet may abet prostate cancer progression
July 2, 2008
NEW YORK (Reuters Health) - Diets high in saturated fat may increase the risk of prostate cancer progression, researchers from the University of Texas M. D. Anderson Cancer Center in Houston report.
|
|
Study shows how broccoli fights cancer
July 2, 2008
LONDON (Reuters) - Just a few more portions of broccoli each week may protect men from prostate cancer, British researchers reported on Wednesday.
|
|
Smokeless tobacco ups oral cancer risk 80 percent
July 2, 2008
LONDON (Reuters) - Chewing tobacco and snuff are less dangerous than cigarettes but the smokeless products still raise the risk of oral cancer by 80 percent, the World Health Organisation's cancer agency said on Tuesday.
|
|
Cells in blood may help cancers spread: US study
July 1, 2008
CHICAGO (Reuters) - Normal cells in the blood that play a role in healing wounds may also be creating the right conditions for cancer cells to spread, U.S. researchers said on Tuesday.
|
|
REFILE: New targeted treatment promising in breast cancer
July 1, 2008
NEW YORK (Reuters Health) - A new experimental chemotherapy combination delivers a targeted, two-pronged attack on breast cancer, researchers report.
|
|
Wealth, health impact colon cancer screening
July 1, 2008
NEW YORK (Reuters Health) - Good intentions don't always translate into action when it comes to colorectal cancer screening, researchers from the UK have found.
|
|
New targeted treatment promising in breast cancer
July 1, 2008
NEW YORK (Reuters Health) - An novel investigational chemotherapy regimen targeting both a mutated protein called p53 and tumor blood vessels "has complementary and potent antitumor activity and could define a new strategy for suppression of advanced breast cancers," Dr. Yayun Liang reported at the Department of Defense's annual Era of Hope breast cancer meeting that just wrapped in Baltimore, Maryland.
|
|
New breast imaging technique seen promising
June 30, 2008
NEW YORK (Reuters Health) - A technique called molecular breast imaging appears to be about as accurate as MRI for detecting breast cancers, but is less costly.
|
|
Glaxo's Cervarix vaccine faces further delay
June 30, 2008
LONDON (Reuters) - GlaxoSmithKline Plc does not expect to win U.S. approval for its key cervical cancer vaccine Cervarix until late 2009, marking a further delay for the product.
|
|
Roche's Avastin prolongs colorectal cancer patients' survival
June 30, 2008
ZURICH (Reuters) - A new study of Roche Holding AG's cancer drug Avastin showed significantly improved survival in patients with metastatic colorectal cancer irrespective of K-Ras gene mutations, the Basel-based drug maker said on Monday.
|
|
Accidental fungus leads to promising cancer drug
June 30, 2008
WASHINGTON (Reuters) - A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S. researchers reported on Sunday.
|
|
Obesity may interfere with prostate cancer screen
June 27, 2008
NEW YORK (Reuters Health) - The test commonly used to screen men for prostate cancer may be more likely to miss tumors in obese men, a new study suggests.
|
|
MRI combo spots prostate cancer treatment failure
June 26, 2008
NEW YORK (Reuters Health) - Two imaging modalities used in combination -- dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI -- can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.
|
|
Estrogen may protect against colorectal cancer
June 25, 2008
NEW YORK (Reuters Health) - Female colon cancer patients who are 50 or younger have much better odds of surviving the disease than their male peers, but the opposite is true of older women with the disease, Australian researchers report.
|
|
Sugar technology has anticancer promise: research
June 25, 2008
NEW YORK (Reuters) - Swiss drugmaker Roche Holding AG on Tuesday said results from a preclinical study suggest that sugar related technology acquired through its purchase of GlycArt Biotechnology AG may boost effectiveness of cancer drugs.
|
|
